SCHEMBL931592

SCHEMBL931592

CC1=NC(Cc2ccccc2)(c2cccc(-c3cncnc3)c2)N=C1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 1.00
BACE2 Q9Y5Z0 2/20 0.53
KCNH2 Q12809 8/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932732 1.00 BACE1 (1.00) BACE1BACE2KCNH2
SCHEMBL6892288 0.81 BACE1 (0.67) BACE1KCNH2
SCHEMBL932777 0.79 BACE1 (0.65) BACE1KCNH2
SCHEMBL6892614 0.77 BACE1 (0.62) BACE1BACE2KCNH2
SCHEMBL946753 0.77 BACE1 (0.62) BACE1BACE2KCNH2
SCHEMBL932353 0.74 BACE1 (0.69) BACE1BACE2KCNH2
SCHEMBL6920218 0.73 BACE1 (0.79) BACE1BACE2KCNH2
SCHEMBL6894146 0.71 BACE1 (0.56) BACE1KCNH2
SCHEMBL932314 0.71 BACE1 (0.76) BACE1BACE2KCNH2
SCHEMBL932620 0.70 BACE1 (1.00) BACE1BACE2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed